{"name":"Irmandade da Santa Casa de Misericordia de Sao Paulo","slug":"irmandade-da-santa-casa-de-misericordia-de-sao-paulo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cimicifuga racemosa","genericName":"Cimicifuga racemosa","slug":"cimicifuga-racemosa","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"clonidine gel 1%","genericName":"clonidine gel 1%","slug":"clonidine-gel-1","indication":"Hypertension","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"ketamine + clonidine","genericName":"ketamine + clonidine","slug":"ketamine-clonidine","indication":"Treatment-resistant depression","status":"phase_3"}]}],"pipeline":[{"name":"Cimicifuga racemosa","genericName":"Cimicifuga racemosa","slug":"cimicifuga-racemosa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"clonidine gel 1%","genericName":"clonidine gel 1%","slug":"clonidine-gel-1","phase":"phase_3","mechanism":"Clonidine is an alpha-2 adrenergic agonist that decreases sympathetic nervous system activity.","indications":["Hypertension","Attention deficit hyperactivity disorder (ADHD)","Menopausal flushing"],"catalyst":""},{"name":"ketamine + clonidine","genericName":"ketamine + clonidine","slug":"ketamine-clonidine","phase":"phase_3","mechanism":"Ketamine acts as an NMDA receptor antagonist, while clonidine is an alpha-2 adrenergic receptor agonist.","indications":["Treatment-resistant depression"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}